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An increasing pressure, exerted on the one hand through ever in-
creasing costs for the development of new drugs, and on the other hand 
by the public, that stipulates animal free research, has led to the devel-
opment of more and more sophisticated in vitro test systems. Among 
them, special attention has to be turned on tissue chips since they have 
got an enormous potential with regard to being developed to true or-
gan-on-chip or even mouse-on-chip-systems due to the organotypic 
behaviour of the cells, at least to some respects.
The replacement of animal experimentation has been payed great 
attention to, at the latest since the introduction of the 3R-concept by 
Russel and Burch [1] and the 4R-principle by Banks [2]. The problems 
with animal experiments are tackled in different ways, like e.g. com-
puter simulation studies, and micro dosing, but most notably by the 
development of appropriate in vitro-systems. 
The development of in vitro-systems, especially 3D-culture systems 
on a chip-basis, experiences an increasing interest in the last decade 
although the remarkable differences between 2D and 3D in cellular be-
haviour have been discovered as early as in the middle of the last centu-
ry. For example, with the help of tumor spheroids it could be shown that 
these multicellular aggregates harbor radiation resistant, hypoxic cells 
that retain their growth potential [3] or that a 3D-configuration is able 
to restore or maintain the diffentiated status of adult cells such as hepa-
tocytes, cardiac myocytes, chondrocytes, and endocrine pancreatic islet 
cells [4]. These developments were enabling technologies to study at 
least partially aspects of whole organ functions. Partially, because of the 
inherent disadvantages of in vitro-techniques of e.g. not being able to 
examine whole organism metabolic responses with its associated drug-
metabolites that are derived by precursors during the first-pass-effect 
for instance. However, the development of more complex tissue chips 
is striving for even more organotypic behavior and is aiming at real 
organ-chips substituting mother nature’s paradigm. One major advan-
tage of those systems could be that they can be equipped with the tissue 
of interest, which means for drug screening purposes, often times hu-
man cells can be used. And even in case the in vitro-model is a simpli-
fied one, the information that can be extracted from it, might resemble 
more closely the human body situation than a whole body experiment 
in the wrong species. It is known, for example, that the half life of acetyl 
salicylic acid in humans is about 20-24 hours, whereas those of cats is 
twice as high and those of horses is just one hour. 
This leads to the conclusion that tissue chips, be they simplified 
models of the whole organ(ism) situation or not are very valuable re-
search tools that are able to reduce costs because of the miniaturization 
that is linked to a low resource consumption and last but not least to 
reduce the consumption of experimental animals. 
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